✦ LIBER ✦

Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity — anin vitrokinetic study

✍ Scribed by K. S. Jagannatha Rao; Gazula Valeswara Rao

Publisher: Springer
Year: 1994
Tongue: English
Weight: 306 KB
Volume: 137
Category: Article
ISSN: 0300-8177
DOI: 10.1007/bf00926039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of monoamine oxidase-A of rat

Inhibition of monoamine oxidase-A of rat brain by pyrethroids — anin vitrokinetic study

✍ Gazula Valeswara Rao; K. S. Jagannatha Rao 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 577 KB

Effect of various antidepressants on bra

Effect of various antidepressants on brain monoamine oxidase activity

✍ E. M. Gankina; T. A. Moskvitina; V. Z. Gorkin; A. V. Val'dman 📂 Article 📅 1982 🏛 Springer US 🌐 English ⚖ 290 KB

The effect of age on the activity and mo

The effect of age on the activity and molecular properties of human brain monoamine oxidase

✍ C. J. Fowler; Å. Wiberg; L. Oreland; J. Marcusson; B. Winblad 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 1015 KB

Effect of some central nervous system ac

Effect of some central nervous system acting drugs on rat brain and liver monoamine oxidase activity

✍ M. Mahfouz; A. B. Makar; M. Th. Ghoneim 📂 Article 📅 1977 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 242 KB

Effect of electric shock on adenosinetri

Effect of electric shock on adenosinetriphosphatase and monoamine oxidase activity in subcellular fractions of the rat brain

✍ R. N. Glebov; V. V. Shevtsov; E. V. Grishankova; I. D. Stal'naya; A. N. Mezentse 📂 Article 📅 1971 🏛 Springer US 🌐 English ⚖ 194 KB

A dose-ranging study of selegiline in pa

A dose-ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity

✍ Nathalie Andreu; Christine Damase-Michel; Jean-Michel Senard; Olivier Rascol; Pr 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB 👁 1 views

## Abstract A dose‐ranging study of selegiline was performed in patients with Parkinson's disease to determine the minimal dosage of the drug able to inhibit ≥95% of platelet monoamine oxidase (MAO) activity. Different doses of selegiline (5 or 10 mg daily, 10 or 20 mg weekly) were studied in four